跳至主要内容
临床试验/JPRN-jRCTs031220564
JPRN-jRCTs031220564尚未招募Unknown

A single-arm intervention trial to verify the efficacy of mAb114 against Ebola virus disease. - mAb-EVD

Morioka Shinichiro0 个研究点目标入组 5 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1) Subjects who have given written informed consent to participate in the study
  • 2) Subjects whose EV RNA was detected by reverse-transcriptase-polymerase-chain-reaction assay (RT-PCR) test using blood, urine, or throat swab samples.

排除标准

  • 1) Persons who are judged inappropriate for inclusion in this research by the research representative or co-investigators
  • 2) Subjects who are considered inappropriate for administration based on the package insert or documents equivalent to the investigator's brochure
  • (3) Patients who have had a severe hypersensitivity reaction to Clozapine should not be administered the drug.

研究者

发起方
Morioka Shinichiro

相似试验